News for hackers. Stuff that matters.
Re:Launch HN: Darmiyan (YC S17) – Early Detection of Alzheim... by x0x0 on Wednesday August 23, 2017 @06:18PM (#15085694)
Why do you think a lack of ability to detect/quantify these micro-structural abnormalities is hindering clinical trials? Is it a problem of detection lag?

How will your tech enable a disease-modifying treatment? Is the hypothesis your tech is the first way we can even measure?

Are you using standard MRIs and just a layer of software, or do you require some sort of special physical device?

This is all curiosity btw; I love the idea. I used to work on software for confocal microscopy and protein melting curves (to be clear, two different labs) before selling out and working on ads.

There are no comments on this comment yet.